Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

Gastroenterology - 1 Mar 2011

Vasen Hans F A, Wasser Martin, van Mil Anneke, Tollenaar Rob A, Konstantinovski Marja, Gruis Nelleke A, Bergman Wilma, Hes Frederik J, Hommes Daniel W, Offerhaus G Johan A, Morreau Hans, Bonsing Bert A, de Vos tot Nederveen Cappel Wouter H

Abstract excerpt

BACKGROUND & AIMS: Surveillance of high-risk groups for pancreatic cancer might increase early detection and treatment outcomes. Individuals with germline mutations in p16-Leiden have a lifetime risk of 15% to 20% of developing pancreatic cancer. We assessed the feasibility of detecting pancreati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Feasibility Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p16

Share to Mass Screening

Share to Netherlands

Share to Pancreas

Share to Precancerous Conditions

Share to Registries

Source

Identifiers

PMID: 21129377
DOI: 10.1053/j.gastro.2010.11.048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21129377-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.PMID 21129377Read ↗

Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.Semantic proximity Read ↗

Development of a high risk pancreatic screening clinic using 3.0 T MRI.Semantic proximity Read ↗

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.Semantic proximity Read ↗

High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers.Semantic proximity Read ↗

Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers.Semantic proximity Read ↗

Pancreatic MRI Findings in High-Risk Individuals Compared With Matched Average-Risk Individuals.Semantic proximity Read ↗

Feasibility and yield of screening in relatives from familial pancreatic cancer families.Semantic proximity Read ↗

A cost analysis of a pancreatic cancer screening protocol in high-risk populations.Semantic proximity Read ↗

Real-world Performance of Multiparametric MRI with Diffusion-Weighted Imaging and MRCP for Pancreatic Cancer SurveillanceSemantic proximity Read ↗

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.Semantic proximity Read ↗

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.Semantic proximity Read ↗

Pancreatic cancer screening: identifying premalignant disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.